Oxford Index Browse

You are looking at 1-10 of 109 items for:

Law x Bioethics x clear all

Refine by type

Refine by product

 

Actions speak louder than images: the use of neuroscientific evidence in criminal cases

Stephen J. Morse.

in Journal of Law and the Biosciences

August 2016; p ublished online June 2016 .

Journal Article. Subjects: Medical and Healthcare Law; Bioethics. 3317 words.

Go to Oxford Journals »  full text: open access

Addressing diversion effects

David B. Resnik.

in Journal of Law and the Biosciences

July 2015; p ublished online April 2015 .

Journal Article. Subjects: Medical and Healthcare Law; Bioethics. 1248 words.

Alan Wertheimer argues that those who promulgate principles of research ethics have a responsibility to take into account the diversion effects of those principles. In this commentary, I...

Go to Oxford Journals »  home page

Affirming the need for a new model for the regulation of drug promotion: a rebuttal to Krause and Zettler

Alan Bennett, Freddy Jiménez and Larry Fields.

in Journal of Law and the Biosciences

April 2016; p ublished online February 2016 .

Journal Article. Subjects: Medical and Healthcare Law; Bioethics. 1558 words.

Go to Oxford Journals »  full text: open access

Are ethics promulgations self-defeating?

Derrick Gray.

in Journal of Law and the Biosciences

July 2015; p ublished online July 2015 .

Journal Article. Subjects: Medical and Healthcare Law; Bioethics. 3085 words.

Alan Wertheimer argues that promulgating some ethical standards of international clinical research may be self-defeating: the intended purpose of these standards is to promote the interests...

Go to Oxford Journals »  full text: open access

Back to first principles: a new model for the regulation of drug promotion

Alan Bennett, Freddy Jiménez, Larry Eugene Fields and Joshua Oyster.

in Journal of Law and the Biosciences

July 2015; p ublished online April 2015 .

Journal Article. Subjects: Medical and Healthcare Law; Bioethics. 23462 words.

The US Food and Drug Administration's (‘FDA’ or the ‘Agency’) current regulatory framework for drug promotion, by significantly restricting the ability of drug manufacturers to communicate...

Go to Oxford Journals »  full text: open access

The blunt-edged sword: genetic explanations of misbehavior neither mitigate nor aggravate punishment

Nicholas Scurich and Paul Appelbaum.

in Journal of Law and the Biosciences

April 2016; p ublished online December 2015 .

Journal Article. Subjects: Medical and Healthcare Law; Bioethics. 7973 words.

Links between genetic variants and negatively valenced behaviors have stimulated intense commentary about the implications for responsibility and punishment. Previous research has suggested...

Go to Oxford Journals »  full text: open access

The brain, cognitive enhancement devices, and European regulation

Andreas Kuersten and Roy H. Hamilton.

in Journal of Law and the Biosciences

September 2014; p ublished online August 2014 .

Journal Article. Subjects: Medical and Healthcare Law; Bioethics. 3534 words.

Go to Oxford Journals »  full text: open access

Buttressing regulation of cognitive enhancement devices with principles of harm reduction

Nicholas S. Fitz and Peter B. Reiner.

in Journal of Law and the Biosciences

September 2014; p ublished online September 2014 .

Journal Article. Subjects: Medical and Healthcare Law; Bioethics. 2210 words.

Maslen and colleagues offer an excellent model for regulating cognitive enhancement devices (CEDs), and we largely endorse their approach of extending medical device policy to include CEDs....

Go to Oxford Journals »  full text: open access

The case for pain neuroimaging in the courtroom: lessons from deception detection

Natalie Salmanowitz.

in Journal of Law and the Biosciences

February 2015; p ublished online February 2015 .

Journal Article. Subjects: Medical and Healthcare Law; Bioethics. 4502 words.

From an observer's perspective, pain is a fairly nebulous concept—it is not externally visible, its cause is not obvious, and perceptions of its intensity are mainly subjective. If...

Go to Oxford Journals »  full text: open access

Clearing complexity from the Common Rule NPRM

Christi J. Guerrini, Amy L. McGuire and Mary A. Majumder.

in Journal of Law and the Biosciences

August 2016; p ublished online June 2016 .

Journal Article. Subjects: Medical and Healthcare Law; Bioethics. 9932 words.

On September 8, 2015, the U.S. Department of Health and Human Services proposed major changes to the regulations known as the Common Rule, whose purpose is to protect human subjects in...

Go to Oxford Journals »  full text: open access